ORIGINAL RESEARCH article

Front. Oncol.

Sec. Head and Neck Cancer

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1554899

This article is part of the Research TopicAdvanced Machine Learning Techniques in Cancer Prognosis and ScreeningView all articles

Predicting the efficacy of chemoradiotherapy in advanced nasopharyngeal carcinoma patients: an MRI radiomics and machine learning approach

Provisionally accepted
  • 1Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
  • 2Department of Radiology, Second Affiliated Hospital of Bengbu Medical College, Bengbu, China

The final, formatted version of the article will be published soon.

Machine learning methods play an important role in predicting the efficacy of chemoradiotherapy in patients with nasopharyngeal carcinoma (NPC). This study explored the predictive value of machine learning models based on multimodal magnetic resonance imaging (MRI) radiomic features for the efficacy in patients with advanced NPC after clinical chemoradiotherapy.A retrospective analysis was conducted on data from 160 diagnosed patients with NPC confirmed by pathology at the First Affiliated Hospital of Bengbu Medical College. Patients were divided into effective group (n=116) and noneffective group (n=44) according to the RECIST 1.1. After the overall Synthetic Minority Over-sampling Technique (SMOTE) sample balance, the proportion of effective group and invalid group is 1:1, both 116 cases, the total sample number is 232 cases. The region of interest (ROI) depicting the maximum solid component of the tumor on T2-weighted imaging short time inversion recovery (T2WI-STIR), contrast-enhanced T1-weighted imaging (CE-T1WI), and diffusion-weighted imaging (DWI) images was delineated, and radiomic features were extracted. Feature selection was performed through least absolute shrinkage and selection operator (LASSO) ridge regression, and based on the selected features, six machine learning models including random forest (RF), Extreme Gradient Boosting (XGBoost), support vector machine (SVM), logistic regression ( LR), Light Gradient Boosting Machine (LGB) and K-nearest neighbor (KNN) were constructed. The model performance of the training set was verified by using the 5-fold cross-validation method, and the effect evaluation and performance visualization were performed on the test set. After that, the SHAP plot was established based on the feature weights, and finally the benefit degree of patients was analyzed using the DCA curve.A total of 3375 radiomic features were extracted, and 25 important features were selected after feature extraction to establish six machine learning models. The RF model exhibited the highest performance, achieving an AUC of 0.801, accuracy of 0.800, precision of 0.844, recall of 0.750, and F1 score of 0.794 within the test set. DCA results showed that patients could get good benefits.The machine learning model based on multimodal MRI radiomic features may serve as a promising tool for predicting the efficacy of chemoradiotherapy in patients with advanced NPC.

Keywords: nasopharyngeal carcinoma, Radiomics, machine learning, efficacy prediction, Magnetic Resonance Imaging

Received: 03 Jan 2025; Accepted: 12 Jun 2025.

Copyright: © 2025 Chen, Wang, Zhang, Meng, Wang, Zhao and Shen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Longshan Shen, Department of Radiology, Second Affiliated Hospital of Bengbu Medical College, Bengbu, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.